<DOC>
	<DOCNO>NCT00261079</DOCNO>
	<brief_summary>Primary objective : - To compare efficacy safety profile Fexofenadine 180mg tablet plus prednicarbate ( 2.5mg/g ) v prednicarbate ( 2.5mg/g ) alone treatment pruritic skin disease Secondary objective : - To evaluate patient 's satisfaction Allegra treatment</brief_summary>
	<brief_title>Fexofenadine Pruritic Skin Disease</brief_title>
	<detailed_description />
	<mesh_term>Pruritus</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<criteria>The following information clinical trial provide information purpose allow patient physician initial discussion trial . This information intend complete information trial , contain consideration may relevant potential participation trial , replace advice personal physician health professional . Main criterion list hereafter : All patient diagnose atopic dermatitis , contact dermatitis Other skin disease except atopic dermatitis , contact dermatitis . Subjects take steroid within 4 week antihistamine within 1 week screen day . Pruritus localize head face Subjects severe hepatic , renal , heart dysfunction . Subjects history alcohol drug abuse . Pregnant lactating woman .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>